Kodiak Sciences (KOD) Operating Income (2017 - 2026)
Kodiak Sciences (KOD) posted Operating Income of -$59.8 million for Q1 2026, down 4.05% on a QoQ basis from -$57.5 million in Q4 2025, and down 1.19% year-over-year from -$60.5 million in Q1 2025.
Kodiak Sciences (KOD) Operating Income (2017 - 2026) Analysis & Trends
Kodiak Sciences' Operating Income history runs 10 years deep, the most recent figure standing at -$59.8 million for Q1 2026.
- Quarterly Operating Income fell 1.19% year-over-year to -$59.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$235.1 million (down 17.62% YoY) and the FY2025 annual result came in at -$234.4 million, down 25.44% from the prior year.
- Operating Income was -$59.8 million for Q1 2026 at Kodiak Sciences, down from -$57.5 million in the prior quarter.
- Across five years, Operating Income topped out at -$46.1 million in Q1 2024 and bottomed at -$95.8 million in Q1 2022.
- A 5-year average of -$64.7 million and a median of -$59.8 million in 2026 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income slumped 89.42% — and 2024, when it surged 43.44%.
- Kodiak Sciences' Operating Income stood at -$74.1 million in 2022, then climbed by 14.44% to -$63.4 million in 2023, then climbed by 27.13% to -$46.2 million in 2024, then dropped by 24.41% to -$57.5 million in 2025, then dropped by 4.05% to -$59.8 million in 2026.
- Business Quant data shows KOD's Operating Income at -$59.8 million in Q1 2026, -$57.5 million in Q4 2025, and -$62.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Kodiak Sciences | 2.56 Bn | 2.56 Bn | - | -59.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.78 Mn |
| Dec 31, 2025 | -57.45 Mn |
| Sep 30, 2025 | -62.35 Mn |
| Jun 30, 2025 | -55.51 Mn |
| Mar 31, 2025 | -59.07 Mn |
| Dec 31, 2024 | -46.18 Mn |
| Sep 30, 2024 | -46.63 Mn |
| Jun 30, 2024 | -47.98 Mn |
| Mar 31, 2024 | -46.06 Mn |
| Dec 31, 2023 | -63.37 Mn |
| Sep 30, 2023 | -54.50 Mn |
| Jun 30, 2023 | -84.83 Mn |
| Mar 31, 2023 | -74.62 Mn |
| Dec 31, 2022 | -74.07 Mn |
| Sep 30, 2022 | -79.48 Mn |
| Jun 30, 2022 | -92.07 Mn |
| Mar 31, 2022 | -95.77 Mn |
| Dec 31, 2021 | -93.05 Mn |
| Sep 30, 2021 | -67.54 Mn |
| Jun 30, 2021 | -55.91 Mn |